Company intelligence / Profile preview

Andara Life Science

Indiana, United States

Ownership: Private
Development stage: Other

Overview

The company developed a proprietary neural stimulation approach for spinal cord injury and broader CNS injury, supported by early clinical data at the time of acquisition; detailed outcomes and trial design are not publicly summarized in accessible high‑level sources.

Therapeutic areas: Neurology
Modalities: DeviceNon-pharmacological therapy
Industry: Therapeutic Medical Devices

Partnerships

Purdue Research Foundation / Purdue University licensing arrangement for paralysis treatment technology (central nervous system injury treatment)

Beyond the preview

Go deeper on Andara Life Science.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Andara Life Science.

Explore the full profile